World Immunotherapy Congress

Cell therapy

• Antigen Targets
• Cell Therapy for solid tumours
• Allogeneic gene therapy

Oncolytic viral therapy and cancer vaccines

• Early stage discovery
• Technological breakthroughs

Combination therapy

• Current development
• Case studies
• Lessons learned
• Challenges

Immunotherapy for solid tumours

• Challenges for solid tumours
• Examples and pre/clinical development

Immune checkpoint inhibitors

• Approved Market Formats
• New Agents
• Combination Agents

Market access

• Investor input
• Regulatory issues
• Commercialisation and manufacture

Clinical trials

• Workshops
• Challenges with clinical trials
• Case studies

Biomarkers

• Technology
• Development
• New biomarkers in development